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RENIN REGULATION
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A Pit-i binding site in the human renin gene promoter stimulates
activity in the pituitary, placental and juxtaglomerular cells. One of the
principal aims of our research is to determine the mechanisms which
direct renin gene expression to different sites. We recently demonstrated
that human renin (hRen) S '-flanking DNA sequences — 148/+11 can drive
the transient expression of a linked luciferase reporter gene transfected
into pituitary GC cells. This activity was found to be dependent on the
binding of Pit-i to a site approximately 70 bp upstream from the
transcription start site. Pit-i is a pituitary-specific transcription factor
which is involved in directing the cell-specific expression of growth
hormone (GH) and prolactin (PRL) gene expression to somatotrope and
lactotrope cells of the anterior pituitary. Thus, Pit-i may be play a role in
directing the expression of renin to primate lactotrope cells. Renin
promoter-driven luciferase or CAT hybrid genes were found to be
expressed following transfection into primary, or early passage cell
cultures of placental chorionic membranes, and the renin-secreting renal
tumor cell line As4.1. As with GC cells, deletion or mutagenesis of the
Pit-i site reduced activity several-fold in both placental and renal cells.
These results suggest that members of the POU family of transcription
factors, or some other closely related group such as the Hox proteins,
participate in directing renin gene expression to placental and juxtaglo-
merular cells.
The renin-angiotensin system (RAS) plays a central role in the
long-term regulation of blood pressure and electrolyte homeosta-
sis, and has been implicated in the control of growth, angiogene-
sis, reproduction, drinking, antidiuretic hormone production, and
catecholamine release from nerve endings [1]. Plasma renin levels
are related to the incidence of stroke, myocardial infarction and
other vascular injuries [2, 3] in hypertensive patients. Understand-
ing the mechanisms which direct renin gene expression to the
renal juxtaglomerular cells may reveal genetic and molecular
bases for defects in both essential [4, 5] and high renin hyperten-
sion [4], and for the paradoxical increase in renin secretion that
nccurs during salt feeding in stroke-prone spontaneously hyper-
tensive rats [6], and Dahl salt-sensitive rats [7]. The mechanisms
which regulate renin gene expression may also provide targets for
new therapies to control hypertension.
In the absence of renal juxtaglomerular cell lines, we and others
ave studied the mechanisms of renin gene expression in cell
uIture systems derived from extrarenal tissues which express
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renin and in transgenic mice. These studies have led to the
development both of specific hypotheses and of reagents and
protocols which are directly relevant and applicable to the study of
JG cell renin expression. The recent development of a renin
secreting cell line (As4.1), which is most likely of juxtaglomerular
origin [8], provides a key reagent to test these hypotheses. In the
present study we show that a common promoter element, the Pit-I
site, which we had previously shown to be active in stimulating
renin promoter activity in pituitary [9], and placental cells (Note
added in proof), is also active in As4.1 cells.
Methods
Renin-luciferase hybrid genes, cell culture and transfection
conditions for GC cells are described elsewhere [9]. The prepa-
ration of placental cell cultures was adapted from [10], and
together with the transfection protocol which involved calcium
phosphate co-precipitation, will be described in detail elsewhere
(manuscript submitted for publication). Transfection of As4.1
cells are also described elsewhere (submitted). For transfection
experiments with As4.1 cells, renin 5'-fianking DNA sequences
were excised as Pstl/HindIII restriction fragments which were
inserted into the similarly digested chloramphenicol acetyl traris-
ferase (CAT) expression vector pPCAT [11]. These constructions
contained the trimerized SV4O polyadenylation sequence (derived
from the parent luciferase constructs) upstream of the promoter
to reduce transcripts originating within the plasmid.
Results
Transfection experiments were carried out using GC cells,
secondary cultures of human placental chorionic membranes
(HC), and As4.1 cells. In all three cell types activities of the hRen
5'-fianking DNA sequences —148/+18 were reduced four- to
fivefold by mutations in the Pit-i site which attenuated Pit-i
binding [91. In experiments with GC and HC cells, activities were
normalized to the activity of RSV./uc transfected in parallel
dishes. The low activities of renin 5'-flanking DNA sequences in
these experiments (i to 2% of RSV.luc) suggest that additional
sequences may also be involved in driving renin gene expression.
Similarly, the CAT activities observed in transfection experiments
with As4.1 cells were low, although no comparisons were made
with an active promoter/enhancer such as the RSV LTR.
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Discussion
Renin and renin mRNA have been detected in pituitary cells of
several species [12—15]. Our recent studies [9] showed that renin
promoter activity in OC cells is correlated with the binding of the
pituitary-specific transcription factor Pit-i. This was confirmed by
experiments in which cotransfection of a Pit-i expression vector
into HeLa cells resulted in the binding site-dependent activation
of the renin promoter. While it is not known whether Pit-i is
involved in directing pituitary expression of the endogenous renin
gene, our findings raised the possibility that other members of the
POU family of transcription factors, or some closely related
factors, might direct renin gene expression in other tissues,
including the placenta and kidney.
Renin and its mRNA have been found in cultures of chorion
laeve and decidua [10, 16, 17] and myometrial tissue which appear
to express high levels of prorenin through several passages [10].
Duncan et al [18] made use of primary cultures of decidua to study
renin gene expression at the level of endogenous renin mRNA
accumulation, and by examining the activity of transfected renin
gene promoter constructs. Their studies suggested that sequences
contained within 100 bp upstream of the transcription start site
are sufficient for placental-specific expression. Our findings fur-
ther delineated the elements involved by demonstrating the strong
contribution made by the Pit-i binding site.
The scarcity of renal juxtaglomerular cells (< 0.01%), has
precluded their isolation and culture for use in studies of renin
gene expression. Although Kurtz and co-workers claimed to have
produced cultures of rat kidneys containing 50 to 90% JO cells
[19, 20], the supporting evidence provided for this level of
enrichment was weak, especially considering that this degree of
purification was achieved through a single Percoll gradient cen-
trifugation step followed by differential plating onto plastic. In
another study [21], similar methods accomplished a modest
10-fold enrichment of JO cells. Even if juxtaglomerular cells could
be prepared in high purity, in culture, these cells rapidly lose the
ability to express renin.
A continuous renal renin-secreting cell line (As4.1) was estab-
lished by targeted tumorigenesis in transgenic animals using
mouse renin (Ren-2) 5'-flanking DNA sequences linked to the SY
40 T antigen [8]. Although their origin has yet to be unequivocally
established as JO cells, the renin promoter fragment used to drive
expression of T antigen in the transgenic mice directs expression
specifically to JO cells. Moreover, these cells constitutively secrete
prorenin, and process prorenin to renin which is stored in
granules and secreted in response to increases in intracellular
cAMP. Since JO cells are the only known site of renin processing,
the cell-specificity of T antigen expression, and the close resem-
blance of renin synthesis and secretion between As4.1 and renal
juxtaglomerular cells, suggest that these cells are indeed of
juxtaglomerular origin. As with pituitary and placental cells,
mutagenesis of the Pit-i site resulted in a substantial loss of
expression.
Studies on the ability of mouse renin 5'-flanking DNA se-
quences to direct the expression of a linked CAT reporter gene
transfected into As4.1 cells [22] showed that sequences extending
to —1.8 kb upstream of the transcription start site possess only
weak promoter activity. However, a segment of Ren-P 5'-flanking
DNA extending to —4.1 kb stimulated CAT activity approximately
12-fold in As4.1 cells but had no effect in the renin non-producing
L cell line. Further studies showed that Ren1t sequences between
—4.1 kb and —2.6 kb exert cell-specific enhancer activity when
linked to more proximal 5'-flanking DNA sequences (—1 171+ 6)
fused to CAT [23].
The weak promoter activity of renin 5'-flanking sequences
observed in the transfection experiments reported here also
suggests that additional elements outside of the proximal 5'-
flanking DNA may be required for cell-specificity and expression
at physiological levels. This hypothesis is supported by the findings
of studies using transgenic mice. Although the mouse Ren-2 gene
containing 2.5 kb of 5'-fianking DNA is sufficient to direct
cell-specific expression of the renin transgene [24], the same 2.5
kb region cannot confer cell-specificity when linked to a reporter
gene [25]. However, in agreement with the results of transfection
experiments in As4.1 cells, 4.6 kb of Ren-2 5'-flanking DNA
confers both cell- and tissue-specificity to the same reporter [26].
Studies of human renin gene expression in transgenic animals
have shown that a renin genomic fragment containing coding,
intervening, 0.9 or 3 kb 5'-flanking DNA, and 0.4 or 1.2 kb
3'-fianking DNA is sufficient for cell-specific expression [27, 28].
Taken together, these data have been interpreted to suggest that
sequences which contribute to cell-specificity are contained down-
stream of the transcription start site, although, at least in the case
of the mouse Ren-2 gene, these may be substituted for by
sequences further upstream in the 5'-flanking DNA [28]. We are
presently searching for putative enhancer elements in more distal
regions of the hRen 5'-flanking DNA, and elsewhere in the
human renin gene which might stimulate transcription from the
human renin gene promoter in As4.1 cells.
Reprint requests to Daniel F. Catanzaro, Ph.D., Cardiovascular Center,
New York Hospital—Cornell University Medical College, 525 East 68th
Street, New York New York USA.
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